IndieBio Team at IndieBio, San Francisco, California, United States — IndieBio is the world’s first startup accelerator. See sector focus and contact routes.
IndieBio is the world’s first startup accelerator exclusively focused on synthetic biology and life sciences, operating as a program of the global venture capital firm SOSV. Its investment thesis targets the earliest pre-seed and seed stages, investing in founders who are scientists or engineers with breakthrough ideas but minimal proof of concept, specifically within health, food, climate, and materials sectors. The firm provides an initial investment of up to $525,000 per company, which is among the largest pre-seed checks in the market, and typically acts as a lead investor by providing wet lab infrastructure and mentorship alongside capital. Notable portfolio companies include Ginkgo Bioworks, Recombinetics, and Chroma, which have collectively raised over $2.3 billion in follow-on funding since IndieBio’s inception. IndieBio distinguishes itself by pioneering deep tech biotech investments at the earliest stages, explicitly targeting founders too early for traditional biotech investors and believing biology should be used as an engineering tool to solve humanity’s greatest challenges. The accelerator has supported over 200 companies that reached an aggre
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in San Francisco.
Investors like IndieBio Team · Full investor directory · Investor access · Company funding database